UnitedHealth Group Incorporated $UNH Position Increased by Van ECK Associates Corp

Van ECK Associates Corp lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 196,810 shares of the healthcare conglomerate’s stock after buying an additional 6,993 shares during the quarter. Van ECK Associates Corp’s holdings in UnitedHealth Group were worth $67,958,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the business. Oberndorf William E acquired a new position in UnitedHealth Group during the 3rd quarter valued at approximately $12,276,000. FourThought Financial Partners LLC grew its position in shares of UnitedHealth Group by 20.6% during the third quarter. FourThought Financial Partners LLC now owns 3,255 shares of the healthcare conglomerate’s stock worth $1,124,000 after acquiring an additional 556 shares during the last quarter. Winthrop Capital Management LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $860,000. Capital Research Global Investors grew its position in UnitedHealth Group by 126.9% in the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares during the last quarter. Finally, Capital World Investors raised its holdings in shares of UnitedHealth Group by 18.8% during the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after buying an additional 3,439,182 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.0%

UnitedHealth Group stock opened at $282.23 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The firm’s 50 day moving average price is $306.41 and its two-hundred day moving average price is $325.71. The firm has a market cap of $256.17 billion, a price-to-earnings ratio of 21.40, a price-to-earnings-growth ratio of 1.31 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same period last year, the company posted $6.81 EPS. The company’s revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.1%. The ex-dividend date is Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on UNH. Morgan Stanley lowered their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research report on Friday, January 23rd. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Leerink Partners lowered their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Finally, JPMorgan Chase & Co. cut their price objective on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday, February 2nd. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.